Oncology & Cancer

Cellular 'racetrack' accurately clocks brain cancer cell movement

Johns Hopkins Medicine researchers report they have developed an experimental laboratory test that accurately clocks the "speed" of human brain tumor cell movement along a small glass "track." The assay, so far tested on ...

Oncology & Cancer

Human trials of cancer drug PAC-1 continue with new investment

Clinical trials of the anti-cancer agent PAC-1 are continuing to expand, thanks to a $7 million angel investment from an anonymous contributor who originally invested $4 million to help get the compound this far in the drug-approval ...

Neuroscience

Key mechanism identified in brain tumor growth

A gene known as OSMR plays a key role in driving the growth of glioblastoma tumors, according to a new study led by a McGill University researcher and published in the journal Nature Neuroscience.

Oncology & Cancer

Scientists find key driver for treatment of deadly brain cancer

Glioblastoma multiforme is a particularly deadly cancer. A person diagnosed with this type of brain tumor typically survives 15 months, if given the best care. The late Senator Ted Kennedy succumbed to this disease in just ...

Oncology & Cancer

New computational strategy finds brain tumor-shrinking molecules

Patients with glioblastoma, a type of malignant brain tumor, usually survive fewer than 15 months following diagnosis. Since there are no effective treatments for the deadly disease, University of California, San Diego researchers ...

page 29 from 40